Publications
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia2022 | First Faculty of Medicine
- TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients2021 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients2020 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood2020 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations2019 | Central Library of Charles University
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients2016 | First Faculty of Medicine, Second Faculty of Medicine
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
Loading network view...